17 July 2019 – trading update

The company has issued a positive trading update for the six months to 30 June with revenues up 29% to £70.3m, with sustained growth from the product portfolio driven by the focus on international markets and higher growth, consumer healthcare products.  Based on trading during the year to date, the company expects revenue and underlying trading profit for the year to be in line with expectations.  Strong cash flow during the period has led to a reduction in debt of £11.7m to £74.1m as at 30 June.  This is expected to reduce rapidly going forward providing scope to take advantage of future growth opportunities.  The shares remain ATTRACTIVE.